Publication:
Retrospective Evaluation of Patients Using Warfarin Admitted to Emergency Department

dc.authorwosidBaydin, Ahmet/Aag-4188-2019
dc.contributor.authorNargis, Cemil
dc.contributor.authorBaydin, Ahmet
dc.contributor.authorKaratas, A. Deniz
dc.contributor.authorGuven, Hakan
dc.contributor.authorDoganay, Zahide
dc.contributor.authorYardan, Turker
dc.date.accessioned2025-12-11T00:36:55Z
dc.date.issued2006
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Nargis, Cemil] Adiyaman Devlet Hastanesi, Acil Serv, Adiyaman, Turkey; [Baydin, Ahmet; Karatas, A. Deniz; Guven, Hakan; Doganay, Zahide] Ondokuz Mayis Univ, Tip Fak, Acil Tip Anabilim Dali, Samsun, Turkey; [Yardan, Turker] Ankara Egitim & Arastirma Hastanesi, Acil Serv, Ankara, Turkeyen_US
dc.description.abstractObjectives: To evaluate the socio-demographics characters of patients taking Warfarin who present to the emergency department with a complaint of bleeding. Materials and Methods: From January 2002 to December 2005, records of patients who were on warfarin and who presented to the ED with a complaint of bleeding were retrospectively reviewed. A standard study form was used to extract data including age, sex, the level of education, the reason for Warfarin treatment, and other concommitent drugs, Warfarin dose and duration of use, International Normalized Ratio level (INR), frequency of INR measurement, CBC, liver function tests. Results: A total of 78 patients [48 women (61.5%) and 30 men (38.5%)] were enrolled in this study. Patients were 28 to 79 (mean 59 +/- 12.4) years old. 41% of patients were illeterate, 51.2% of patients had education at the 5th grade level. 32.1% of all patients were admitted to the emergency department with gastrointestinal bleeding and 55.1% of patients used a non-steroidal anti-inflammatory drug in addition to Warfarin., Only 26.9% of patients had their INR measured every month. Conclusion: Better education of patients on Warfarin, regular international normalized ratio control and reduction of additional drug application may reduce the major bleeding frequency in the next survival of these patients.en_US
dc.description.woscitationindexEmerging Sources Citation Index
dc.identifier.endpage59en_US
dc.identifier.issn2452-2473
dc.identifier.issue2en_US
dc.identifier.scopusqualityQ3
dc.identifier.startpage56en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/37892
dc.identifier.volume6en_US
dc.identifier.wosWOS:000420989000002
dc.language.isotren_US
dc.publisherElsevier Science Bven_US
dc.relation.ispartofTurkish Journal of Emergency Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAnticoagulants/Administrationen_US
dc.subjectDosageen_US
dc.subjectAnticoagulants/Adverse Effectsen_US
dc.subjectVenous Thrombosis/Drug Therapyen_US
dc.subjectWarfarin/Administrationen_US
dc.subjectDosage/Adverse Effectsen_US
dc.titleRetrospective Evaluation of Patients Using Warfarin Admitted to Emergency Departmenten_US
dc.typeArticleen_US
dspace.entity.typePublication

Files